NovaQuest hits hard cap in latest fund

NovaQuest Private Equity held the final close of its second fund at $500 million after less than seven months of fundraising. Like the firm’s preceding fund that started to deploy capital 2018, NovaQuest Private Equity Fund II is managed by ...

Read more

NovaQuest backs German pharma’s osteoarthritis treatment

NovaQuest Capital Management expanded is royalty pipeline with a deal to support development of German pharmaceutical firm Grünenthal's lead asset, the osteoarthritis product candidate resiniferatoxin (RTX). Under the newly announced deal, NovaQuest will reimburse Grünenthal’s investments into late-stage studies of ...

Read more

Log In/Out


Start your day on top of things with our daily alts news briefing

Get our FREE daily newsletter


Subscribe to AW

Welcome Back!

Login to your account below

Retrieve your password

Please enter your username or email address to reset your password.